The global Genetic Material market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Genetic Material is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genetic Material is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Genetic Material in Proteomics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Genetic Material include Abbott Laboratories, Bio-Rad Laboratories, Myriad Genetics, Danaher, F. Hoffmann-La Roche, Eurofins Scientific, Illumina, QIAGEN and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genetic Material, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Material.
Report Scope
The Genetic Material market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetic Material market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Material companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Bio-Rad Laboratories
Myriad Genetics
Danaher
F. Hoffmann-La Roche
Eurofins Scientific
Illumina
QIAGEN
Novartis
Thermo Fisher Scientific
Agilent Technologies
Empire Genomics
FUJIFILM Irvine Scientific
PerkinElmer Genomics
Ruhof
Segment by Type
DNA
RNA
Genes
Chromosomes
Segment by Application
Proteomics
Bioinformatics
Synthetic Biology
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Material companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Material Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA
1.2.3 RNA
1.2.4 Genes
1.2.5 Chromosomes
1.3 Market by Application
1.3.1 Global Genetic Material Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Proteomics
1.3.3 Bioinformatics
1.3.4 Synthetic Biology
1.3.5 Drug Discovery
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Material Market Perspective (2019-2030)
2.2 Genetic Material Growth Trends by Region
2.2.1 Global Genetic Material Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genetic Material Historic Market Size by Region (2019-2024)
2.2.3 Genetic Material Forecasted Market Size by Region (2025-2030)
2.3 Genetic Material Market Dynamics
2.3.1 Genetic Material Industry Trends
2.3.2 Genetic Material Market Drivers
2.3.3 Genetic Material Market Challenges
2.3.4 Genetic Material Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Material Players by Revenue
3.1.1 Global Top Genetic Material Players by Revenue (2019-2024)
3.1.2 Global Genetic Material Revenue Market Share by Players (2019-2024)
3.2 Global Genetic Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Material Revenue
3.4 Global Genetic Material Market Concentration Ratio
3.4.1 Global Genetic Material Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Material Revenue in 2023
3.5 Genetic Material Key Players Head office and Area Served
3.6 Key Players Genetic Material Product Solution and Service
3.7 Date of Enter into Genetic Material Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Material Breakdown Data by Type
4.1 Global Genetic Material Historic Market Size by Type (2019-2024)
4.2 Global Genetic Material Forecasted Market Size by Type (2025-2030)
5 Genetic Material Breakdown Data by Application
5.1 Global Genetic Material Historic Market Size by Application (2019-2024)
5.2 Global Genetic Material Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Genetic Material Market Size (2019-2030)
6.2 North America Genetic Material Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genetic Material Market Size by Country (2019-2024)
6.4 North America Genetic Material Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetic Material Market Size (2019-2030)
7.2 Europe Genetic Material Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genetic Material Market Size by Country (2019-2024)
7.4 Europe Genetic Material Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Material Market Size (2019-2030)
8.2 Asia-Pacific Genetic Material Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genetic Material Market Size by Region (2019-2024)
8.4 Asia-Pacific Genetic Material Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetic Material Market Size (2019-2030)
9.2 Latin America Genetic Material Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genetic Material Market Size by Country (2019-2024)
9.4 Latin America Genetic Material Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Material Market Size (2019-2030)
10.2 Middle East & Africa Genetic Material Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genetic Material Market Size by Country (2019-2024)
10.4 Middle East & Africa Genetic Material Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Genetic Material Introduction
11.1.4 Abbott Laboratories Revenue in Genetic Material Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Genetic Material Introduction
11.2.4 Bio-Rad Laboratories Revenue in Genetic Material Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Detail
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Genetic Material Introduction
11.3.4 Myriad Genetics Revenue in Genetic Material Business (2019-2024)
11.3.5 Myriad Genetics Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Genetic Material Introduction
11.4.4 Danaher Revenue in Genetic Material Business (2019-2024)
11.4.5 Danaher Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Genetic Material Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Genetic Material Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Eurofins Scientific
11.6.1 Eurofins Scientific Company Detail
11.6.2 Eurofins Scientific Business Overview
11.6.3 Eurofins Scientific Genetic Material Introduction
11.6.4 Eurofins Scientific Revenue in Genetic Material Business (2019-2024)
11.6.5 Eurofins Scientific Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Genetic Material Introduction
11.7.4 Illumina Revenue in Genetic Material Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Detail
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Genetic Material Introduction
11.8.4 QIAGEN Revenue in Genetic Material Business (2019-2024)
11.8.5 QIAGEN Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Genetic Material Introduction
11.9.4 Novartis Revenue in Genetic Material Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Genetic Material Introduction
11.10.4 Thermo Fisher Scientific Revenue in Genetic Material Business (2019-2024)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Detail
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies Genetic Material Introduction
11.11.4 Agilent Technologies Revenue in Genetic Material Business (2019-2024)
11.11.5 Agilent Technologies Recent Development
11.12 Empire Genomics
11.12.1 Empire Genomics Company Detail
11.12.2 Empire Genomics Business Overview
11.12.3 Empire Genomics Genetic Material Introduction
11.12.4 Empire Genomics Revenue in Genetic Material Business (2019-2024)
11.12.5 Empire Genomics Recent Development
11.13 FUJIFILM Irvine Scientific
11.13.1 FUJIFILM Irvine Scientific Company Detail
11.13.2 FUJIFILM Irvine Scientific Business Overview
11.13.3 FUJIFILM Irvine Scientific Genetic Material Introduction
11.13.4 FUJIFILM Irvine Scientific Revenue in Genetic Material Business (2019-2024)
11.13.5 FUJIFILM Irvine Scientific Recent Development
11.14 PerkinElmer Genomics
11.14.1 PerkinElmer Genomics Company Detail
11.14.2 PerkinElmer Genomics Business Overview
11.14.3 PerkinElmer Genomics Genetic Material Introduction
11.14.4 PerkinElmer Genomics Revenue in Genetic Material Business (2019-2024)
11.14.5 PerkinElmer Genomics Recent Development
11.15 Ruhof
11.15.1 Ruhof Company Detail
11.15.2 Ruhof Business Overview
11.15.3 Ruhof Genetic Material Introduction
11.15.4 Ruhof Revenue in Genetic Material Business (2019-2024)
11.15.5 Ruhof Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
Bio-Rad Laboratories
Myriad Genetics
Danaher
F. Hoffmann-La Roche
Eurofins Scientific
Illumina
QIAGEN
Novartis
Thermo Fisher Scientific
Agilent Technologies
Empire Genomics
FUJIFILM Irvine Scientific
PerkinElmer Genomics
Ruhof
*If Applicable.